BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12565011)

  • 1. Nonleadlikeness and leadlikeness in biochemical screening.
    Rishton GM
    Drug Discov Today; 2003 Jan; 8(2):86-96. PubMed ID: 12565011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
    Rishton GM
    Curr Opin Chem Biol; 2008 Jun; 12(3):340-51. PubMed ID: 18328272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of high-content analysis for compound screening and target selection.
    Rausch O
    IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations.
    Rishton GM
    Med Chem; 2005 Sep; 1(5):519-27. PubMed ID: 16787336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate pharmaceutical profiling for drug discovery.
    Kerns EH; Di L
    Curr Top Med Chem; 2002 Jan; 2(1):87-98. PubMed ID: 11899067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.
    Zhao H
    Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution phase combinatorial chemistry.
    Merritt AT
    Comb Chem High Throughput Screen; 1998 Jun; 1(2):57-72. PubMed ID: 10500766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Management in Early Discovery Medicinal Chemistry.
    Singh G; Dahlin JL; Walters MA
    Methods Enzymol; 2018; 610():1-25. PubMed ID: 30390795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based lead discovery.
    Rees DC; Congreve M; Murray CW; Carr R
    Nat Rev Drug Discov; 2004 Aug; 3(8):660-72. PubMed ID: 15286733
    [No Abstract]   [Full Text] [Related]  

  • 12. High throughput screening: early successes indicate a promising future.
    Fox S; Wang H; Sopchak L; Khoury R
    J Biomol Screen; 2001 Jun; 6(3):137-40. PubMed ID: 11689109
    [No Abstract]   [Full Text] [Related]  

  • 13. Extraction of structure-activity relationship information from high-throughput screening data.
    Wawer M; Bajorath J
    Curr Med Chem; 2009; 16(31):4049-57. PubMed ID: 19754425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of automated systems relevant in pharmaceutical salt screening.
    Kumar L; Amin A; Bansal AK
    Drug Discov Today; 2007 Dec; 12(23-24):1046-53. PubMed ID: 18061884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying small-molecule lead compounds: the screening approach to drug discovery.
    Bevan P; Ryder H; Shaw I
    Trends Biotechnol; 1995 Mar; 13(3):115-21. PubMed ID: 7766218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.
    Alanine A; Nettekoven M; Roberts E; Thomas AW
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):51-66. PubMed ID: 12570752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput drug discovery: what can we expect from HTS?
    Gribbon P; Sewing A
    Drug Discov Today; 2005 Jan; 10(1):17-22. PubMed ID: 15676295
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of methods for sequential screening of large compound sets.
    Blower PE; Cross KP; Eichler GS; Myatt GJ; Weinstein JN; Yang C
    Comb Chem High Throughput Screen; 2006 Feb; 9(2):115-22. PubMed ID: 16475969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.